06/08/2026
Starting July 1, 2026, Medicare beneficiaries can access FDA-approved GLP-1 weight loss medications for just $50 a month through a new federal program called the Medicare GLP-1 Bridge. The program runs through December 31, 2027, and requires Medicare Part D enrollment, a qualifying BMI, and prior authorization from CMS. The process involves multiple steps across your doctor, your insurance plan, and a centralized CMS processor — and it's easy to get stuck or delayed without the right help. This article walks you through everything you need to know to get approved.
Link below.....
https://www.solace.health/articles/medicare-glp-1-bridge-program?utm_source=google&utm_medium=cpc&utm_campaign=pmax_chronic_condition_nav_general_intent&utm_term=&utm_content=&placement=&gad_source=1&gad_campaignid=22767728156&gbraid=0AAAAApABHIks13Gnr4Lni_fqiZ7I_ynSV&gclid=Cj0KCQjw0JnRBhDJARIsALobnXYfW8cwr80Q_7O6aH0-0A_Z6cObRnA8z__RWJcG00pqqE1sEFqDAZ4aAv9FEALw_wcB